Fibroblast Growth Factor Signaling in Metabolic Regulation

Vera J M Nies1, Gencer Sancar2, Weilin Liu1

  • 1Center for Liver, Digestive and Metabolic Diseases, Department of Pediatrics, University Medical Center Groningen, University of Groningen , Groningen , Netherlands.

Insights

Fibroblast growth factors (FGFs) show promise for treating metabolic diseases like obesity and diabetes. Understanding FGF signaling mechanisms is key to developing effective FGF-based therapies with fewer side effects.

Area of Science:

  • Metabolic diseases
  • Endocrinology
  • Molecular biology

Background:

  • Obesity is a growing health concern linked to serious comorbidities like type 2 diabetes and non-alcoholic fatty liver disease.
  • Current treatments for metabolic diseases often have adverse effects.
  • Fibroblast growth factors (FGFs) play a crucial role in regulating energy metabolism.

Purpose of the Study:

  • To review the physiological roles of FGF signaling in metabolic homeostasis.
  • To discuss the pharmacological properties and effector tissues of FGFs in metabolic disease.
  • To summarize recent advancements in FGF variant development for therapeutic applications.

Main Methods:

  • Literature review of current research on FGF signaling in metabolic health and disease.
  • Analysis of the known and potential therapeutic applications of FGFs and their derivatives.
  • Examination of the molecular mechanisms underlying FGF action.

Main Results:

  • FGF1, FGF19, and FGF21 exhibit beneficial metabolic effects.
  • FGF signaling pathways are critical for maintaining metabolic balance.
  • Developing FGF variants offers potential for targeted therapies with improved safety profiles.

Conclusions:

  • FGFs represent a promising therapeutic avenue for metabolic conditions.
  • Further understanding of FGF molecular mechanisms is essential for optimizing FGF-based treatments.
  • Targeted FGF therapies could offer improved efficacy and reduced side effects for metabolic diseases.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
4.3K